| 4901 |
Cord Tissue |
Allogeneic – Unrelated |
Secondary Progressive Multiple Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
64 |
| 4902 |
Cord Tissue |
Allogeneic – Unrelated |
Secondary Progressive Multiple Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
54,6 |
| 4903 |
Cord Tissue |
Allogeneic – Unrelated |
Secondary Progressive Multiple Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
59,5 |
| 4904 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2019 |
Experimental Therapy |
Poland |
5,11 |
| 4905 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2019 |
Experimental Therapy |
Poland |
10 months |
| 4906 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2019 |
Experimental Therapy |
Poland |
10 months |
| 4907 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2019 |
Experimental Therapy |
Poland |
5,11 |
| 4908 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida; Epilepsy |
Neurology |
2019 |
Experimental Therapy |
Poland |
2,2 |
| 4909 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2019 |
Experimental Therapy |
Poland |
33 |
| 4910 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
no data |
| 4911 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2019 |
Experimental Therapy |
Poland |
27,5 |
| 4912 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2019 |
Experimental Therapy |
Poland |
26,9 |
| 4913 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
38,6 |
| 4914 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
27,8 |
| 4915 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
41,1 |
| 4916 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Muscular Atrophy |
Neurology |
2019 |
Experimental Therapy |
Poland |
11 |
| 4917 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2019 |
Experimental Therapy |
Poland |
40 |
| 4918 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2019 |
Experimental Therapy |
Poland |
26,1 |
| 4919 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2019 |
Experimental Therapy |
Poland |
54,11 |
| 4920 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2019 |
Experimental Therapy |
Poland |
37 |
| 4921 |
Cord Tissue |
Allogeneic – Unrelated |
Stargardt's Disease |
Ophthalmology |
2019 |
Experimental Therapy |
Poland |
30,5 |
| 4922 |
Cord Tissue |
Allogeneic – Unrelated |
Stargardt's Disease |
Ophthalmology |
2019 |
Experimental Therapy |
Poland |
40 |
| 4923 |
Cord Tissue |
Allogeneic – Unrelated |
Status After Meningitis And Encephalitis; Encephalopathy |
Neurology |
2019 |
Experimental Therapy |
Poland |
4 |
| 4924 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Turkey |
2 |
| 4925 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
6 |
| 4926 |
Cord Blood |
Autologous |
Autism |
Neurology |
2019 |
Experimental Therapy |
Poland |
3,6 |
| 4927 |
Cord Blood |
Autologous |
Autism |
Neurology |
2019 |
Experimental Therapy |
Poland |
10,5 |
| 4928 |
Cord Blood |
Autologous |
Autism |
Neurology |
2019 |
Experimental Therapy |
Germany |
4 |
| 4929 |
Cord Blood |
Autologous |
Brain Damage |
Neurology |
2019 |
Experimental Therapy |
Germany |
11 months |
| 4930 |
Cord Blood |
Autologous |
Brain Damage |
Neurology |
2019 |
Experimental Therapy |
Germany |
1,5 |
| 4931 |
Cord Blood |
Allogeneic – Related |
Brain Damage |
Neurology |
2019 |
Experimental Therapy |
Germany |
7 |
| 4932 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2019 |
Experimental Therapy |
UK |
3 |
| 4933 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2019 |
Experimental Therapy |
Poland |
4,5 |
| 4934 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2019 |
Experimental Therapy |
Poland |
8,8 |
| 4935 |
Cord Blood |
Allogeneic – Related |
Fanconi Anemia |
Hematology |
2019 |
Standard Therapy |
Turkey |
12,4 |
| 4936 |
Cord Blood |
Autologous |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Portugal |
4 |
| 4937 |
Cord Blood |
Allogeneic – Related |
Severe Chronic Neutropenia |
Hematology |
2019 |
Standard Therapy |
Germany |
6 |
| 4938 |
Cord Blood |
Allogeneic – Related |
Thalassemia |
Hematology |
2019 |
Standard Therapy |
Turkey |
5,5 |
| 4939 |
Cord Blood |
Allogeneic – Related |
Thalassemia |
Hematology |
2019 |
Standard Therapy |
Turkey |
5,11 |
| 4940 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Turkey |
5,1 |
| 4941 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Turkey |
3,5 |
| 4942 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Turkey |
12 |
| 4943 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Turkey |
16 |
| 4944 |
Bone Marrow Family |
Allogeneic |
Activated Pi3k Delta Syndrome (Apds) |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 4945 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
59 |
| 4946 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
57 |
| 4947 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
73 |
| 4948 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 4949 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 4950 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
57 |
| 4951 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 4952 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 4953 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 4954 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
29 |
| 4955 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
23 |
| 4956 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 4957 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 4958 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
23 |
| 4959 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 4960 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
5 |
| 4961 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
72 |
| 4962 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
14 |
| 4963 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 4964 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
72 |
| 4965 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 4966 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
22 |
| 4967 |
Bone Marrow Family |
Allogeneic |
Glanzmann Thrombasthenia |
Hematology |
2019 |
Standard Therapy |
Poland |
11 |
| 4968 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 4969 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
78 |
| 4970 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 4971 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
60 |
| 4972 |
Bone Marrow Family |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
48 |
| 4973 |
Bone Marrow Family |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
56 |
| 4974 |
Bone Marrow Family |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 4975 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 4976 |
Bone Marrow Family |
Allogeneic |
Refractory Anemia With Blast Excess Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
53 |
| 4977 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
27 |
| 4978 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
52 |
| 4979 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
5 |
| 4980 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
21 |
| 4981 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
17 |
| 4982 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 4983 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
15 |
| 4984 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
64 |
| 4985 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
2 |
| 4986 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
17 |
| 4987 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
11 |
| 4988 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
51 |
| 4989 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
8 |
| 4990 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 4991 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
3 |
| 4992 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
10 |
| 4993 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
13 |
| 4994 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
15 |
| 4995 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
5 |
| 4996 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
3 |
| 4997 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 4998 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
14 |
| 4999 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5000 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
10 |